Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Purified inactivated Japanese encephalitis vaccine (Vero cell) in 6–11 month healthy infants
CTR20140471Phase 3Completed
- Sponsor
- Shandong Hengye Biotechnology Co., Ltd.
- Start
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Vero cell-derived inactivated Japanese Encephalitis vaccine in Japanese encephalitis (JE), sponsored by Shandong Hengye Biotechnology Co., Ltd.. Started Dec 2014; status: completed.
02
Drugs
Vero cell-derived inactivated Japanese Encephalitis vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on CTR20140471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140471.